19 min listen
ASHP Advantage: Where Do We Go from Here? Discussing the Future of Eosinophilic Esophagitis Treatment
FromASHPOfficial
ASHP Advantage: Where Do We Go from Here? Discussing the Future of Eosinophilic Esophagitis Treatment
FromASHPOfficial
ratings:
Length:
13 minutes
Released:
Mar 25, 2022
Format:
Podcast episode
Description
Hear experts discuss the FDA’s recent Complete Response Letter CRL regarding Takeda’s budesonide oral solution for eosinophilic esophagitis (EoE), what therapies are in the pipeline for EoE and their potential role in therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Released:
Mar 25, 2022
Format:
Podcast episode
Titles in the series (100)
Tips and Tricks for Staying Updated on Best Practices and Literature: Join members of the ASHP New Practitioners Forum Clinical Practice Advisory Group as they share advice for student pharmacists, pharmacy residents and new practitioners on tips and tricks for staying updated on best practices and review of the litera... by ASHPOfficial